Trials / Unknown
UnknownNCT03946384
Mutation p.Ile112Thr : Discrepancy Between Factor IX Level and Bleeding Phenotype
Discrepancy Between Factor IX Level and Bleeding Phenotype
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (estimated)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
It appears that the mutation p.Ile112Thr in the factor IX gene confers a discrepancy between mild factor IX level and severe bleeding phenotype. Databases and litterature analysis are poor on this matter. The goal of this study is to compile bleeding phenotype in patients with this specific mutation to prove the clinico-biological discordance in order to improve patient care and follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | data collection | data collection on the history of the disease, hemophilia |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2019-10-01
- Completion
- 2019-10-01
- First posted
- 2019-05-10
- Last updated
- 2019-05-10
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03946384. Inclusion in this directory is not an endorsement.